<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gomez-Mejia A</submitter><funding>Swiss National Science Foundation</funding><pagination>e0043024</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11520294</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(10)</volume><pubmed_abstract>The human pathobiont &lt;i>Streptococcus pyogenes&lt;/i> forms biofilms and causes infections, such as pharyngotonsillitis and necrotizing fasciitis. Bacterial biofilms are more resilient to antibiotic treatment, and new therapeutic strategies are needed to control biofilm-associated infections, such as recurrent pharyngotonsillitis. &lt;i>Lactiplantibacillus plantarum&lt;/i> and &lt;i>Lacticaseibacillus rhamnosus&lt;/i> are two bacterial commensals used for their probiotic properties. This study aimed to elucidate the anti-biofilm properties of &lt;i>L. plantarum&lt;/i> and &lt;i>L. rhamnosus&lt;/i> cell-free supernatants (LPSN and LRSN, respectively) on &lt;i>S. pyogenes&lt;/i> biofilms grown &lt;i>in vitro&lt;/i> in supplemented minimal medium. When planktonic or biofilm &lt;i>S. pyogenes&lt;/i> were exposed to LPSN or LRSN&lt;i>, S. py</pubmed_abstract><journal>mSphere</journal><pubmed_title>Inhibition of &lt;i>Streptococcus pyogenes&lt;/i> biofilm by &lt;i>Lactiplantibacillus plantarum&lt;/i> and &lt;i>Lacticaseibacillus rhamnosus&lt;/i>.</pubmed_title><pmcid>PMC11520294</pmcid><funding_grant_id>169962</funding_grant_id><funding_grant_id>204343</funding_grant_id><funding_grant_id>310030</funding_grant_id><pubmed_authors>Mairpady Shambat S</pubmed_authors><pubmed_authors>Gomez-Mejia A</pubmed_authors><pubmed_authors>Orlietti M</pubmed_authors><pubmed_authors>Zinkernagel AS</pubmed_authors><pubmed_authors>Tarnutzer A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of &lt;i>Streptococcus pyogenes&lt;/i> biofilm by &lt;i>Lactiplantibacillus plantarum&lt;/i> and &lt;i>Lacticaseibacillus rhamnosus&lt;/i>.</name><description>The human pathobiont &lt;i>Streptococcus pyogenes&lt;/i> forms biofilms and causes infections, such as pharyngotonsillitis and necrotizing fasciitis. Bacterial biofilms are more resilient to antibiotic treatment, and new therapeutic strategies are needed to control biofilm-associated infections, such as recurrent pharyngotonsillitis. &lt;i>Lactiplantibacillus plantarum&lt;/i> and &lt;i>Lacticaseibacillus rhamnosus&lt;/i> are two bacterial commensals used for their probiotic properties. This study aimed to elucidate the anti-biofilm properties of &lt;i>L. plantarum&lt;/i> and &lt;i>L. rhamnosus&lt;/i> cell-free supernatants (LPSN and LRSN, respectively) on &lt;i>S. pyogenes&lt;/i> biofilms grown &lt;i>in vitro&lt;/i> in supplemented minimal medium. When planktonic or biofilm &lt;i>S. pyogenes&lt;/i> were exposed to LPSN or LRSN&lt;i>, S. py</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-15T14:50:30.511Z</modification><creation>2025-04-04T01:02:42.366Z</creation></dates><accession>S-EPMC11520294</accession><cross_references><pubmed>39360839</pubmed><doi>10.1128/msphere.00430-24</doi></cross_references></HashMap>